Today: 1 May 2026
Western Digital stock jumps 11% as storage shares rally on AI demand signals

Western Digital stock jumps 11% as storage shares rally on AI demand signals

New York, Jan 28, 2026, 13:16 EST — Regular session

  • Shares of Western Digital surged about 11% in afternoon trading, reaching a fresh intraday high.
  • Storage shares rose, led by Seagate after upbeat signals pointed to stronger data-center demand.
  • Investors will zero in on Western Digital’s quarterly report Thursday after the bell.

Shares of Western Digital Corp jumped 11.2% to $280.94 in afternoon trading, extending a two-day rally and reaching a new intraday high of $281.61. Seagate Technology soared 19.7%, while Sandisk and Micron Technology gained 8.8% and 5.6%, respectively.

Western Digital is now at the center of a trade boosting hardware stocks, fueled by expectations that data-center spending will stay strong. Investors are also bracing for the company’s upcoming earnings report, which often sets the tone for the sector with its guidance on drive pricing and shipment volumes.

The broader market sentiment was a key factor. The S&P 500 surpassed 7,000 points for the first time Wednesday, driven by investor enthusiasm around AI just ahead of the Federal Reserve’s policy announcement later that day. “You could definitely have a continuation on the rally in equities if … AI expenditure is bringing in revenues,” said Jeff Leschen, managing director at Bramshill Investments. Reuters

Seagate’s optimistic forecast fueled Wednesday’s jump in storage stocks, as the company forecasted quarterly revenue and profits surpassing Wall Street’s estimates. The surge highlights growing enterprise demand tied to AI expansion, which is driving large-scale data storage needs. “Modern data centers increasingly need storage solutions that combine performance and cost-efficiency at exabyte-scale,” said Seagate CEO Dave Mosley. Reuters

Western Digital, after spinning off its flash division into Sandisk last year, is now fully focused on hard disk drives. This puts the company in a prime position to reflect demand trends for high-capacity drives in cloud data centers.

Western Digital was already on the move before Wednesday. On Tuesday, its shares climbed 4.9%, closing at $252.66. That outpaced competitors and marked a second consecutive day at a fresh 52-week high, according to MarketWatch data.

Analysts are digging in. Mizuho raised its price target on Western Digital to $265 from $240, holding onto an outperform rating, according to TheFly. Investors are debating just how long tight supply and strong demand can sustain these high prices.

The immediate focus is pricing. Investors want updates on whether average selling prices and volumes for “nearline” hard drives—the large-capacity drives used in data center storage—are still rising, and whether supply bottlenecks are easing or worsening.

The trade is crowded. If hyperscalers—the biggest cloud giants—begin scaling back orders or if drive prices fall as supply ramps up, this group could face a sharp setback. A Fed that turns more hawkish than expected could also dampen risk appetite for AI-related stocks.

Western Digital is scheduled to release its fiscal second-quarter earnings after markets close on Thursday, Jan. 29. The company will host a conference call at 4:30 p.m. Eastern.

Stock Market Today

  • Seaport Therapeutics Upsizes IPO to $255M, CEO Highlights New Biotech Pathway
    May 1, 2026, 2:02 PM EDT. Seaport Therapeutics raised $254.9 million in an upsized Nasdaq IPO, exceeding initial $180 million estimates. CEO Daphne Zohar highlighted a shift from traditional M&A (mergers and acquisitions) to public offerings, reflecting confidence in developing and marketing their depression drug pipeline independently. The company may raise an additional $38.2 million through underwriters' option. Zohar pointed to industry changes where biotech firms are now focusing on advancing medicines directly to patients, citing success stories like Karuna Therapeutics and Intra-Cellular Therapies. Seaport's board recently welcomed Sharon Mates, who led Intra-Cellular to a $1.5 billion drug launch before its J&J acquisition. This IPO signals renewals in the biotech public market despite recent Big Pharma dealmaking.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Eli Lilly stock drops today: LLY slides after $1.12 billion gene-editing deal and Medicare pricing signal
Previous Story

Eli Lilly stock drops today: LLY slides after $1.12 billion gene-editing deal and Medicare pricing signal

Why Intuitive Machines (LUNR) stock is up today: NASA Artemis II tracking role, fresh $26 target
Next Story

Why Intuitive Machines (LUNR) stock is up today: NASA Artemis II tracking role, fresh $26 target

Go toTop